Financial Data and Key Metrics Changes - For the full year 2025, the company generated total revenues of $266 million and AFFO of $205 million, with a cash flow from operations of approximately $200 million [4][5] - In Q4 2025, total revenues were $66.7 million, and AFFO totaled $53.3 million, or $1.88 per share, representing a 10% improvement compared to Q3 2025 AFFO of $1.71 per share [20][21] - The company raised over $145 million of attractively priced debt and preferred equity since October 2025, including a new $100 million revolving credit facility [21][22] Business Line Data and Key Metrics Changes - The company executed new leases at 4 properties totaling approximately 339,000 sq ft in 2025, reinforcing the quality of its assets [5][12] - The strategic investment in IQHQ amounted to $275 million, with $150 million funded to date, indicating a focus on diversifying the portfolio [5][18] Market Data and Key Metrics Changes - The life science sector is showing early signs of renewed momentum, with improving capital availability and increased strategic activity among large pharmaceutical companies [6][19] - The current construction pipeline for life science real estate is at its lowest level since early 2019, indicating a stabilization in the market [18][19] Company Strategy and Development Direction - The company is focused on a diversified portfolio across cannabis and life science, aiming to strengthen its platform and deliver long-term value for shareholders [7][8] - The recent executive order to reschedule cannabis to Schedule III is viewed as a significant regulatory development that could improve operator cash flows and strengthen credit profiles [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term fundamentals supporting the life science sector and noted that discussions at the J.P. Morgan Healthcare Conference reinforced this conviction [6][19] - The company believes it is at an inflection point regarding previously non-performing assets and expects future quarters to reflect earnings upside from re-leasing efforts [11][12] Other Important Information - The company exited 2025 with total liquidity exceeding $105 million, including cash and availability under credit facilities [6][22] - Legal proceedings related to non-performing tenants are ongoing, with significant progress reported in receivership cases [11][12] Q&A Session Summary Question: Are cannabis operators looking to expand again, or are they looking to move up the quality spectrum with new space? - Management indicated that experienced operators are taking advantage of weaker competitors, and there are unique opportunities in the market [28][29] Question: How does the approach differ between competitive states like Massachusetts and Michigan? - Management noted that understanding the nuances of each market is crucial, and they focus on identifying successful operators [33][34] Question: Can you provide details on new rental rates for 4Front assets compared to prior rates? - Management stated that rental rates vary widely, with some deals significantly below prior rates and others close to them [41][42] Question: What is the outlook for legal costs this year? - Management indicated that legal costs are hard to estimate but are primarily related to tenant defaults and receivership processes [66][69]

Group 1 - The acquisition of Hawthorne Gardening from Scotts Miracle-Gro by Vireo Growth is expected to significantly enhance Vireo's operations and market position in the cannabis industry [2][6] - Vireo Growth has rapidly expanded its footprint, increasing its dispensaries from 16 to 166 across 10 states, and has made several strategic acquisitions to bolster its market presence [8][9] - The company reported a revenue of $164 million for the first nine months of the year, reflecting a 121% year-over-year increase, and an adjusted EBITDA of $45 million, up 145% compared to the previous year [7] Group 2 - The acquisition of Hawthorne is anticipated to provide Vireo with vertical integration, leading to cost savings and improved quality control over its products [6] - Vireo's cash position was $117 million at the end of the third quarter, indicating a strong financial base to capitalize on opportunities in a distressed cannabis market [7] - Despite the growth and potential benefits of acquisitions, there are concerns regarding the complexities and costs associated with rapid expansion, as well as the company's increasing debt of $60.8 million [9]

Summary of NewLake Capital Partners Update Call Company Overview - **Company Name**: NewLake Capital Partners (OTCPK:NLCP) - **Business Model**: Sale-leaseback REIT focused on cannabis real estate - **Market Position**: Second largest owner of cannabis real estate in the U.S. with 34 properties across 12 states - **Lease Structure**: Average remaining lease term of 12 years and a yield of approximately 13% on leased portfolio [5][6] Financial Performance - **Dividend Growth**: 80% growth in dividends since IPO in mid-2021, although growth has leveled off due to market conditions [7][8] - **Tenant Composition**: Top three tenants (Curaleaf, Cresco, Trulieve) account for about 50% of annualized base rent [7] - **Comparison with Non-Cannabis REITs**: Non-cannabis REITs have lower yields (6%-7%) compared to NewLake's 13% [10][12] Market Dynamics - **Cannabis Sector Sentiment**: The sentiment in the cannabis sector has softened, impacting deal-making and growth strategies [8] - **Comparison with Other Financing Options**: Sale-leaseback REITs provide longer duration and potentially higher proceeds compared to BDCs and mortgage REITs, which typically have shorter transaction durations [14][17] Regulatory Environment - **International Opportunities**: Interest in exploring deals outside the U.S., including Canada and Europe, but regulatory uncertainties remain a concern [22][58] - **Impact of Rescheduling**: Anticipated positive effects from potential rescheduling of cannabis, including increased demand for services and improved credit quality for tenants [60][61] Tenant Issues and Portfolio Management - **Recent Tenant Recoveries**: Properties from Ayr and Rev Clinics have been recovered and are being re-tenanted for cannabis purposes [89][92] - **Proactive Tenant Relationships**: NewLake aims to maintain strong relationships with tenants to maximize returns and address issues collaboratively [95] Investor Considerations - **Dividend Yield**: Attractive low to mid-teens dividend yield, but concerns about discount to NAV and market perception of leverage and dividend sustainability [38][44] - **Market Positioning**: NewLake's focus on a diversified portfolio of cannabis real estate may provide lower volatility compared to direct cannabis operators [36][37] Future Outlook - **Potential for Increased Deal Flow**: Positive regulatory changes could lead to more opportunities in 2026 and 2027, although current activity remains cautious [60][61] - **Challenges Ahead**: The company faces challenges in gaining a listing on major exchanges due to federal cannabis laws, despite potential regulatory changes [79][81]

Financial Data and Key Metrics Changes - Total revenues for Q3 2025 were $64.7 million, a 3% increase compared to the prior quarter, primarily due to a $0.8 million payment from the Gold Flora receivership and annual rent escalations [14] - Adjusted funds from operations (AFFO) totaled $48.3 million, or $1.71 per share, representing no change from the second quarter results [14] - The company ended the quarter with nearly $80 million in liquidity, including cash on hand and availability under its credit facility [14][15] - The balance sheet remains strong, supported by $2.7 billion in primarily unencumbered gross assets and a low-leverage capital structure with a debt-to-gross assets ratio of 13% [14][16] Business Line Data and Key Metrics Changes - The company completed its initial investment of $105 million into IQHQ, a life science real estate platform, which is expected to enhance diversification and provide significant earnings accretion [4][5] - Year-to-date, the company executed leases totaling 281,000 sq ft across properties in California and Michigan [11] - The investment in IQHQ is expected to be highly accretive, with a blended interest rate exceeding 14% [16] Market Data and Key Metrics Changes - The cannabis industry is seeing a growing interest from operators, with demographic trends indicating that seniors are the fastest-growing consumer segment, with usage growing at a 9% five-year compounded annual growth rate [9] - Global spending on AI and pharma and biotech is projected to reach $3 billion in 2025 and $16.5 billion by 2034, reflecting a 27% CAGR [12] Company Strategy and Development Direction - The company is diversifying its portfolio beyond cannabis into the life science sector, which is expected to capture long-term secular growth [5][6] - The dual-track strategy aims to enhance shareholder value and position the company for sustained success across both industries [6] - The company is actively evaluating its capital structure and exploring strategic financing alternatives to align with long-term growth objectives [17] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism regarding the cannabis industry's future, citing potential federal cannabis reform and the positive demographic trends among seniors [9][42] - The company remains cautious about the timing of federal rescheduling but believes it could unlock broader access to capital and accelerate institutional participation [9][42] - Management highlighted ongoing legal proceedings and receivership situations but expressed confidence in regaining control of properties and the potential for significant revenue from administrative claims [20][25] Other Important Information - The U.S. Court of Appeals for the Third Circuit affirmed the dismissal of a federal securities class action against the company, allowing it to focus on executing its strategy [10] - The company has taken back possession of four California properties previously securing a loan totaling $16.1 million, which was declared in default [8] Q&A Session Summary Question: Dividend expectations and timing of rent commencements - Management discussed the potential contributions from the IQHQ investment and backfill leases to the dividend policy, indicating a quick timeline for revenue from receivership assets [18][20] Question: Balance sheet and refinancing options - Management confirmed plans to refinance maturing unsecured bonds and expressed confidence in the strength of the balance sheet [31][32] Question: Impact of rescheduling on growth opportunities - Management noted that while rescheduling could improve operator credit and cash flow, the company is focused on supporting existing tenants and exploring new opportunities in both cannabis and life sciences [40][46] Question: Current status of ABR and tenant issues - Management reported that approximately 20% of ABR is currently not rent-paying, down from 27% previously, reflecting improvements in tenant health [56][58] Question: Future occupancy expectations at IQHQ - Management expects IQHQ's occupancy to reach 90% within the next 18 to 24 months, with ongoing interest in the facilities [52] Question: Balancing capital needs between cannabis and life sciences - Management emphasized a strong balance sheet and the importance of seeking unique investment opportunities while maintaining a focus on the cannabis industry [60][61]

Core Insights - The Canadian cannabis market is crucial for the global marijuana industry, with U.S. legalization efforts expected to drive growth and cross-border opportunities [1][15] - Leading Canadian cannabis stocks are gaining investor attention due to improving financials and international expansion, particularly Cronos Group, Aurora Cannabis, and OrganiGram [2][15] Industry Overview - The U.S. cannabis industry is projected to exceed $56 billion by 2030, driven by expanding state programs and rising consumer acceptance [1] - Discussions around federal reclassification and potential legalization are creating optimism in both Canadian and American markets [1] Company Summaries Cronos Group - Cronos Group operates several global brands and has an indirect presence in the U.S. through a partnership with PharmaCann, which operates over twenty dispensaries [3][6] - The company exited the U.S. CBD market in 2023 to focus on higher-margin international products, improving operational efficiency and long-term growth potential [3][6] - Financially, Cronos reported steady revenue growth in 2024, reduced operating losses, and a strong balance sheet supported by Altria Group [6][8] Aurora Cannabis - Aurora Cannabis is a leader in the global cannabis sector with large-scale cultivation facilities and a focus on medical and recreational products [8][10] - The company has positioned itself for U.S. market entry upon federal legalization and has a strong international presence in Europe, Australia, and South America [8][10] - Aurora achieved revenue growth in 2025, positive gross margins, and a small net income after years of losses, reflecting a notable financial recovery [10] OrganiGram Holdings - OrganiGram is recognized for its agility and rapid growth, enhancing its international presence through partnerships and the recent acquisition of Motif Labs [11][13] - The company achieved record quarterly revenues and positive adjusted EBITDA in 2025, driven by strong sales of premium products and improved production efficiency [13] - OrganiGram's focus on higher-margin segments and global export potential continues to attract investor interest, with positive trends in its financial performance [13][14]

Financial Data and Key Metrics Changes - The company generated total revenues of $71.7 million, a 6.5% decrease from the previous quarter, primarily due to tenant defaults [14][15] - Adjusted funds from operations (AFFO) for the first quarter were $55.3 million, or $1.94 per share, representing a 13% decrease compared to the fourth quarter of 2024 [15][16] - The balance sheet remained solid with $2.6 billion in gross assets, nearly $2.2 billion of which are unencumbered [15][16] Business Line Data and Key Metrics Changes - The company executed two new leases totaling 211,000 square feet, including a significant lease for a 205,000 square foot property in Michigan with Berry Green [13][14] - Year to date, the company acquired a $7.8 million industrial facility in Maryland and sold a cultivation facility in Michigan for $9 million [5][13] Market Data and Key Metrics Changes - The U.S. cannabis sales are forecasted to grow by 7% to $33.5 billion in 2025, with a projected compounded annual growth rate of 7.2% from 2024 to 2029, reaching $44.4 billion by 2029 [11][12] - The company is facing competition from the illicit market, price compression, and market maturity, which may impact investor sentiment and operator performance [12] Company Strategy and Development Direction - The company is focused on optimizing occupancy across its portfolio and strengthening tenant credit profiles [5][8] - A strategic initiative was announced to refresh a portion of the tenant base to position the company for sustainable growth [8][9] - The company is actively pursuing legal remedies for nonpaying tenants and is encouraged by the progress made in retenanting properties [10][12] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the ongoing uncertainty in the macroeconomic environment and its impact on economic forecasts and business planning [5][8] - There is confidence in the strength of the business and the opportunities ahead, with expectations of a recovery in the tenant base within 18 to 36 months [29][60] Other Important Information - The company repurchased $20 million of its common stock and retired nearly $9 million of debt at a discount [7][16] - The company issued $10 million of preferred equity to enhance its capital structure [7][16] Q&A Session Summary Question: Is the 205,000 square feet leased in Michigan a PharmaCann facility? - Yes, it is a PharmaCann facility, and the company is proud of retenanting it quickly with a high-quality tenant [19][20] Question: How did the recent large block leasing transactions come together? - The sourcing of tenants comes from various channels, leveraging strong relationships and networking in the industry [21][23] Question: Are there concerns about other tenants' operations since the announcement of the tenant refresh program? - The company is monitoring all tenants and is confident in managing the portfolio, although the macro environment remains challenging [28][29] Question: How much of the security deposits were applied to revenue in the quarter? - $5.8 million of security deposits were applied for the quarter, which will not be available in subsequent quarters [38] Question: What is the status of properties waiting for rent commencement due to approvals? - The company does not believe this changes their view on the markets, as delays in approvals are standard across industries [40][41] Question: How does the company ensure compliance when taking possession of properties? - The company utilizes management service agreements to facilitate transitions and ensure compliance with regulations [47][48] Question: What opportunities for investment are being evaluated with the available liquidity? - The company is focused on identifying opportunities that provide accretive returns based on their cost of capital and has a pipeline of unique opportunities within the cannabis industry [59][60]

Financial Data and Key Metrics Changes - The company generated total revenues of $71.7 million, a 6.5% decrease from the previous quarter, primarily due to tenant defaults [14][15] - Adjusted funds from operations (AFFO) for the first quarter were $55.3 million, or $1.94 per share, reflecting a 13% decrease compared to the fourth quarter of 2024 [15][16] - The balance sheet remained solid with $2.6 billion in gross assets, nearly $2.2 billion of which are unencumbered [15][16] Business Line Data and Key Metrics Changes - The company acquired a $7.8 million industrial facility in Maryland and executed two new leases totaling 211,000 square feet [4][12] - A cultivation facility in Michigan was sold for $9 million, demonstrating the company's focus on strategic investments and capital recycling [4][12] Market Data and Key Metrics Changes - The U.S. cannabis sales are forecasted to grow by 7% to $33.5 billion in 2025, with a projected compounded annual growth rate of 7.2% from 2024 to 2029, reaching $44.4 billion by 2029 [10][11] - The company is facing competition from the illicit market, price compression, and market maturity, which may impact investor sentiment and operator performance [11] Company Strategy and Development Direction - The company is proactively working to refresh its tenant base to position itself for sustainable growth and financial performance [6][10] - A strategic initiative was announced to strengthen tenant credit profiles and optimize occupancy across the portfolio [4][6] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the ongoing uncertainty in the macroeconomic environment and the regulated cannabis market [3][4] - The management team is optimistic about the opportunities ahead and believes they are effectively managing complex situations to protect shareholder value [7][10] Other Important Information - The company repurchased $20 million of its common stock and retired nearly $9 million of debt at a discount, highlighting a disciplined approach to capital allocation [5][16] - Default notices were issued to several tenants, and the company is actively pursuing legal remedies to enhance the performance of its real estate portfolio [8][9] Q&A Session Summary Question: Is the 205,000 square feet leased in Michigan a PharmaCann facility? - Yes, it is a PharmaCann facility, and the company is proud of re-tenanting it quickly with a high-quality tenant [19] Question: How did the recent large block leasing transactions come together? - The sourcing of tenants comes from various methods, leveraging strong relationships and networking in the industry [24] Question: Are there any other tenants of concern since the tenant refresh program was announced? - The company is monitoring all tenants and is confident in managing the portfolio, although the macro environment remains challenging [29] Question: What is the impact of security deposits on revenue moving forward? - Approximately $5.8 million of security deposits were applied for the quarter, which will not be available in subsequent quarters [37] Question: How does the company ensure compliance when taking possession of properties? - The company utilizes management service agreements to facilitate transitions and ensure compliance with regulations [46] Question: What are the potential opportunities for deploying liquidity? - The company is evaluating various opportunities and remains focused on investments that can provide accretive returns based on their cost of capital [58]

Core Viewpoint - Real estate investment trusts (REITs) are popular among income-seeking investors due to their requirement to distribute most earnings as dividends, but they face challenges that can threaten dividend payouts [1] Group 1: Innovative Industrial Properties (IIP) - IIP focuses on the medical cannabis industry by purchasing real estate from marijuana growers and leasing it back to them [2] - The cannabis industry has faced difficulties, impacting IIP's operations, including declining revenue and earnings, and a significant tenant, PharmaCann, defaulting on rent obligations, which accounted for about 17% of IIP's rental revenue [4] - A deal was reached with PharmaCann for repayment of owed rent and a new lease agreement, while IIP continues to own 109 properties across 19 states, with medical cannabis legal in 38 states [5] - IIP has maintained its dividend despite recent challenges, appealing to investors looking for resilient dividend options [6] Group 2: Medical Properties Trust (MPT) - MPT operates medical facilities and has faced issues with two tenants declaring bankruptcy, leading to financial difficulties and reduced payouts [7] - MPT has begun addressing these challenges by securing new tenants for facilities previously occupied by Steward Health Care, with average lease terms of about 18 years [8] - MPT has 396 medical properties across the U.S. and Europe, and despite recent challenges, it is expected to benefit from long-term trends in the healthcare sector, such as an aging population [9] Group 3: Investment Comparison - IIP generates higher funds from operations and has a significantly higher annual dividend per share and trailing-12-month dividend yield compared to MPT [11] - MPT operates in the medical industry, which has strong long-term prospects, while the future of the cannabis sector remains uncertain [12] - The uncertainty surrounding the cannabis industry raises questions about IIP's future performance, while MPT is expected to gradually return to stable financial results and increase dividends [13] - The choice between IIP and MPT depends on investor preferences, with bullish investors on cannabis favoring IIP and risk-averse investors opting for MPT [14]